MARKET

GOVX

GOVX

Geovax Labs Inc
NASDAQ
1.110
-0.160
-12.60%
After Hours: 1.149 +0.039 +3.51% 19:53 03/28 EDT
OPEN
1.260
PREV CLOSE
1.270
HIGH
1.265
LOW
1.100
VOLUME
606.54K
TURNOVER
--
52 WEEK HIGH
11.18
52 WEEK LOW
1.090
MARKET CAP
15.36M
P/E (TTM)
-0.1206
1D
5D
1M
3M
1Y
5Y
1D
GeoVax Labs Advances Vaccine Trials and Expands Operations
TipRanks · 1d ago
GeoVax Labs Earnings Call: Mixed Sentiments and Strategic Plans
TipRanks · 1d ago
Roth MKM Sticks to Their Buy Rating for GeoVax Labs (GOVX)
TipRanks · 1d ago
Based on the provided financial report articles, the title of the article is: "FORM 10-K: GEOVAX LABS, INC. (0000832489) - Annual Report for the fiscal year ended December 31, 2024
Press release · 2d ago
Here are the major earnings after the close today
Seeking Alpha · 3d ago
Earnings Scheduled For March 27, 2025
Benzinga · 3d ago
What's Next: Geovax Labs's Earnings Preview
Benzinga · 3d ago
BRIEF-GeoVax Labs Inc - Enters Placement Agency And Securities Purchase Agreements With A.G.P./Alliance Global Partners - SEC Filing
Reuters · 4d ago
More
About GOVX
More
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan and Marburg), Zika virus and malaria, as well as immunotherapies for multiple solid tumors. The Company’s portfolio of wholly owned, co-owned, and in-licensed intellectual property, stands at over 155 granted or pending patent applications spread over 24 patent families. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02 and others. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations.
Recently
Symbol
Price
%Change

Webull offers Geovax Labs Inc stock information, including NASDAQ: GOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOVX stock methods without spending real money on the virtual paper trading platform.